Medicamen Bio is not listed on NSE
AnnouncementsMedicamen Biotech; Outcome of board meeting
AnnouncementsMedicamen Biotech: Board meeting on March 31, 2014
AnnouncementsMedicamen Biotech: Updates on outcome of EGM
AnnouncementsMedicamen Biotech: Outcome of EGM
No recommendations so far.What's your call on Medicamen Bio today?
|Company Name||Last Price||%
|Dr Reddys Labs||3222.45||0.32||3240.00||2420.00||54,899.54|
|Mar' 14||Dec' 13||Sep' 13||Jun' 13|
|No Mutual Funds Holding the share|
Vaibhav Global Recommended on Jun 11th 2014
Recommended price 675.00 | Peak from reco 975.00 44.44%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Medicamen Bio is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 14.26 crore.The company has reported a standalone sales of Rs 22.39 crore and a Net Loss of Rs -0.44 crore for the quarter ended Mar 2014.
The company management includes B K Gupta - Managing Director, Jitendra Nath Ojha - Whole Time Director, Sanjay Bansal - Director, Ashutosh Gupta - Director, Rajinder Kr Gupta - Director, M L Parnami - Director, J N Ojha - Director, Harshita Sharma - Additional Director.
It is listed on the BSE with a BSE Code of 531146.
Its Registered office is at 10 Community Centre, No. 2 Ashok Vihar,,Phase-II Delhi,Delhi - 110052.
Their Registrars are Link Intime India Pvt. Ltd.